Search for: "James D. Stephens v. the United States"
Results 161 - 180
of 216
Sorted by Relevance
|
Sort by Date
15 Apr 2022, 4:09 am
Treasury Department’s anti-money laundering unit ha [read post]
11 Oct 2019, 7:12 am
(With the exception of a mid-September media law conference in central London featuring Justice Stephen Breyer, all other events we tracked this summer took place in the United States.) [read post]
23 May 2009, 11:26 am
Feng, Peter, Stephen D. [read post]
17 Oct 2022, 11:35 am
See, e.g., Stephen P. [read post]
25 Dec 2017, 9:40 pm
Supreme Court’s recent decision in Endrew F. v. [read post]
25 Dec 2017, 9:40 pm
Supreme Court’s recent decision in Endrew F. v. [read post]
25 Oct 2007, 8:27 pm
[37] V. [read post]
15 Jan 2023, 2:35 pm
”[8] This text states that a corporation’s cooperation with the government’s investigation is a mitigating factor by which a corporation can gain credit. [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its… [read post]
1 Feb 2019, 10:51 am
The political economy of international standard setting in financial reporting: how the United States led the adoption of IFRS across the world. [read post]
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate heats up at BIO: (Managing… [read post]
15 Mar 2008, 7:00 am
Shame about the IP: (Afro-IP),Ethiopia receives US trade mark for Sidamo coffee despite opposition from Starbucks: (The IP Factor), (Afro-IP),CC licensed test for African sleeping sickness: (creativecommons.org),Update on PCT applications filed in Nigeria: (Afro-IP),Parallel imports of DVDs to be tested in South Africa: Universal City Studios v Mr Video: (Afro-IP),The W****D C*P of 2*1*: FIFA’s intellectual property rights in South Africa: (Afro-IP),Namibia to… [read post]
1 Jun 2012, 7:02 am
James. [read post]
1 Nov 2024, 5:00 am
Feng, Peter, Stephen D. [read post]
5 Aug 2024, 12:52 pm
Feng, Peter, Stephen D. [read post]
22 Oct 2024, 10:28 pm
Feng, Peter, Stephen D. [read post]
15 Nov 2024, 7:23 pm
Feng, Peter, Stephen D. [read post]
30 Nov 2024, 2:29 pm
Feng, Peter, Stephen D. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
6 Dec 2013, 11:55 am
For example, produce has, since at least 1991, been the source of substantial numbers of outbreak-related E. coli O157:H7 infections.[19] Other unusual vehicles for causing E. coli O157:H7 infections have included apple juice, yogurt, dried salami, and mayonnaise.[20] According to a recent study, an “estimated 73,480 illnesses due to E. coli O157:H7 infections occur each year in the United States, leading to an estimated 2,168 hospitalizations and sixty-one… [read post]
